64 related articles for article (PubMed ID: 26259382)
1. Penetrance and phenotypic effects of C/T polymorphism at 1595 position in exon 5 of the TRAIL gene among prostate cancer patients in Pakistani population.
Farooqi AA; Mansoor Q; Fayyaz S; Ismail M
J Exp Ther Oncol; 2015; 11(1):1-3. PubMed ID: 26259382
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population.
Zahoor A; Mansoor Q; Farooqi AA; Fayyaz S; Naz G; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):108-12. PubMed ID: 26518902
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
[TBL] [Abstract][Full Text] [Related]
5. Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population.
Rehman SF; Mansoor Q; Farooqi AA; Nazir N; Kausar R; Jabeen N; Ismail M
Contemp Oncol (Pozn); 2016; 20(2):185-7. PubMed ID: 27358600
[TBL] [Abstract][Full Text] [Related]
6. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
Mittal RD; Mandal RK; Gangwar R
Mech Ageing Dev; 2012 Apr; 133(4):127-32. PubMed ID: 22019847
[TBL] [Abstract][Full Text] [Related]
7. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
[TBL] [Abstract][Full Text] [Related]
9. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
10. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
11. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
12. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
15. Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor.
Pal R; Gochhait S; Chattopadhyay S; Gupta P; Prakash N; Agarwal G; Chaturvedi A; Husain N; Husain SA; Bamezai RN
Breast Cancer Res Treat; 2011 Apr; 126(2):333-43. PubMed ID: 20443055
[TBL] [Abstract][Full Text] [Related]
16. Association between the TRAIL single nucleotide polymorphism rs1131580 and type 2 diabetes mellitus in a Han Chinese population.
Yu MY; Zhao PQ; Yan XH; Liu B; Zhang QQ; Wang R; Ma CH; Liang XH; Zhu FL; Gao LF
Genet Mol Res; 2013 Sep; 12(3):3455-64. PubMed ID: 24065684
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluating the FGFR4 (G388R) germline mutation in different cancers in Pakistani population.
Mansoor Q; Fayyaz S; Farooqi AA; Bhatti S; Ismail M
J Exp Ther Oncol; 2013; 10(3):215-7. PubMed ID: 24416997
[TBL] [Abstract][Full Text] [Related]
18. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
